AHCO: financial statements from SEC — TradeAlmanac

AHCO

AdaptHealth Corp.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	3.24bn	3.26bn
Cost of revenue	2.64bn	2.58bn
Selling, general and administrative	382m	359m
Operating expenses	3.19bn	3.00bn
Operating income	91m	264m
Pre-tax income	−15m	136m
Income tax	51m	41m
Net income	−71m	90m
Earnings per share	−0.52	0.62
Earnings per share, diluted	−0.52	0.61
Weighted average shares	135m	134m
Weighted average shares, diluted	135m	136m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	48m	106m	80m	69m	54m	110m	100m	70m
Receivables	392m	371m	380m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	602m	542m
Depreciation and amortisation	382m	365m
Share-based compensation	22m	15m
Capital expenditure	382m	306m
Investing cash flow	−303m	−310m
Share buybacks	0

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)